Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: A cohort study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 4, 2012, Pages 557-566

  Alexiou, V G ^a,b   Michalopoulos, A ^a,c   Makris, G C ^a   Peppas, G ^a,c   Samonis, G ^a,d   Falagas, M E ^a,c,e  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c HENRY DUNANT HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTINEOPLASTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME AXETIL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; METRONIDAZOLE; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; COHORT ANALYSIS; DRUG UTILIZATION; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; OPERATION DURATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL PATIENT; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84862863558     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1347-2     Document Type: Article

References (42)

1. Klevens RM, Edwards JR, Richards CL Jr et al (2007) Estimating health care-associated infections and deaths in U.S. Hospitals, 2002. Public Health Rep 122:160-166
2. Paun BC, Cassie S, MacLean AR et al (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251 (Suppl 5):807-818
3. Delgado-Rodríguez M, Gómez-Ortega A et al (1999) Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery. J Hosp Infect 41(Suppl 3):203-211 (Pubitemid 29123654)
4. Richards MJ, Edwards JR, Culver DH, Gaynes RP (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21 (Suppl 8):510-515 (Pubitemid 30647154)
5. Lee CY, Chen PY, Huang FL, Lin CF (2009) Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience. J Microbiol Immunol Infect 42(Suppl 2):160-165
6. Gaynes R, Edwards JR (2005) National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848-854 (Pubitemid 41266753)
7. Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362(Suppl 19):1804-1813
8. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5:24
9. Falagas ME, Rafailidis PI, Ioannidou E et al (2010) Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 35(Suppl 2):194-199
10. Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12
11. Falagas ME, Karageorgopoulos DE (2008) Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46(Suppl 7):1121-1122 (Pubitemid 351589881)
12. Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64:7-15 (Pubitemid 44161380)
13. del Mar TM, Cartelle M, Pertega S et al (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11:540-546 (Pubitemid 40895153)
14. Carbonne A, Naas T, Blanckaert K et al (2005) Investigation of a nosocomial outbreak of extended-spectrum betalactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect 60:14-18 (Pubitemid 40485845)
15. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005) Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11:22-29 (Pubitemid 40093348)
16. Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E et al (2005) Acinetobacter baumannii ventilator associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649-655 (Pubitemid 40684982)
17. Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283-289 (Pubitemid 40216539)
18. Maslow JN, Glaze T, Adams P, Lataillade M (2005) Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 26:69-75 (Pubitemid 40110971)
19. Maragakis LL, Cosgrove SE, Song X et al (2004) An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292:3006-3011 (Pubitemid 39665302)
20. Lee SO, Kim NJ, Choi SH, Hyong Kim T et al (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 48:224-248
21. Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA (2002) Risk factors for piperacillintazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46:854-858 (Pubitemid 34157674)
22. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340-345 (Pubitemid 34062234)
23. Lee SC, Fung CP, Liu PY et al (1999) Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infect Control Hosp Epidemiol 20:205-207
24. Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094-1098 (Pubitemid 27513193)
25. Peersman G, Laskin R, Davis J, Peterson MG, Richart T (2006) Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2(Suppl 1):70-72 (Pubitemid 44421784)
26. Horan TC, Gaynes RP (2004) Surveillance of nosocomial infections. In: Mayhall CG (ed) Hospital epidemiology and infection control, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1659-1702
27. Iversen LH, Bülow S, Christensen IJ, Laurberg S, Harling H, Danish Colorectal Cancer Group (2008) Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg 95(Suppl 8):1012-1019
28. Haridas M, Malangoni MA (2008) Predictive factors for surgical site infection in general surgery. Surgery 144(Suppl 4):496-503
29. Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF (2007) Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 204(Suppl 6):1178-1187 (Pubitemid 46819099)
30. Brown S, Kurtsikashvili G, Alonso-Echanove J et al (2007) Prevalence and predictors of surgical site infection in Tbilisi, Republic of Georgia. J Hosp Infect 66(Suppl 2):160-166 (Pubitemid 46832064)
31. Fariñas-Alvarez C, Fariñas MC, Fernández-Mazarrasa C, Llorca J, Casanova D, Delgado-Rodríguez M (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87 (Suppl 8):1076-1081 (Pubitemid 30496859)
32. Jeon MH, Choi SH, Kwak YG et al (2008) Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 62(Suppl 4):402-406
33. Edmond MB, Ober JF, Weinbaum DL et al (1995) Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20(Suppl 5):1126-1133
34. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD (1998) Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 26(Suppl 5):1127-1133 (Pubitemid 28215477)
35. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL (1987) Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 55 (Suppl 11):2689-2694 (Pubitemid 17154509)
36. Wells CL, Jechorek RP, Maddaus MA, Simmons RL (1988) Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 32(Suppl 12):1769-1775
37. Wells CL, Maddaus MA, Jechorek RP, Simmons RL (1988) Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 7(Suppl 1):107-113 (Pubitemid 18069197)
38. Chastre J, Wolff M, Fagon JY, Chevret S et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(Suppl 19):2588-2598 (Pubitemid 37443289)
39. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505-511 (Pubitemid 30647191)
40. Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283-289 (Pubitemid 40216539)
41. Donaldson AD, Razak L, Liang LJ, Fisher DA, Tambyah PA (2009) Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter? Int J Antimicrob Agents 34(Suppl 3):246-251
42. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373-1379 (Pubitemid 27028925)